45
6.4.1.3. Smoking Cessation in TAA
COR LOE
Recommendation
1 C-LD 1. In patients with TAA who smoke cigarettes, smoking
cessation efforts are recommended.
6.4.1.4. Antiplatelet Therapy in TAA
COR LOE
Recommendation
2a C-EO 1. In patients with atherosclerotic TAA and concomitant aortic
atheroma or PAU, the use of low-dose aspirin is reasonable,
unless contraindicated.
6.4.2.1. BP Management in AAA
COR LOE
Recommendation
1 B-NR 1. In patients with AAA and an average SBP of ≥130 mm Hg, or
an average DBP of ≥80 mm Hg, the use of antihypertensive
medication is recommended to reduce risk of cardiovascular
events.
6.4.2.2. Treatment of AAA With Statins
COR LOE
Recommendations
1 B-NR 1. In patients with AAA and evidence of aortic atherosclerosis,
statin therapy at moderate or high intensity is recommended.
2b C-LD 2. In patients with AAA but no evidence of atherosclerosis, statin
therapy may be considered.
6.4.2.3. Smoking Cessation in AAA
COR LOE
Recommendation
1 C-LD 1. In patients with AAA who smoke cigarettes, smoking
cessation efforts are recommended.
6.4.2.4. Antithrombotic Therapy in AAA
COR LOE
Recommendation
2b C-LD 1. In patients with AAA with concomitant atheroma and/or
PAU, the use of low-dose aspirin may be considered, unless
contraindicated.
